| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
Denis Angioletti
BRD | Director/Board Member | 58 | 01/01/2020 |
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| -2.48% | +8.34% | +53.87% | +155.75% | 1,070B | |
| -1.76% | +6.23% | +66.27% | +53.44% | 611B | |
| -1.05% | +7.19% | +35.57% | +86.77% | 445B | |
| -1.31% | +4.18% | +31.11% | +23.88% | 329B | |
| +0.36% | +1.42% | +35.63% | +35.99% | 290B | |
| +0.40% | +1.71% | +29.17% | +42.83% | 287B | |
| 0.00% | +0.85% | -28.32% | -41.95% | 213B | |
| +0.44% | +4.35% | +29.69% | +63.10% | 195B | |
| +0.01% | +1.03% | +13.95% | +63.93% | 157B | |
| Average | -0.51% | +5.04% | +29.66% | +53.75% | 399.58B | |
| Weighted average by Cap. | -1.15% | +6.67% | +40.27% | +78.37% |
Employees
4
Sector
Pharmaceuticals
